{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"49"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"74"}],"units":"Participants"}],"description":"Number of participants from ASCT to death or last contact","groups":[{"description":"Patients with refractory or relapsed myeloma received high-dose GemBuMel with ASCT","id":"OG000","title":"Gemcitabine/Busulfan/Melphalan"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"From date of transplant until the date of death from any cause, assessed up to 2 years","title":"Overall Survival","type":"SECONDARY","unitOfMeasure":"Participants"}